News & Blog
News & Blog
Meet The Community: Márcia Ferreira Galvão
Larimar Therapeutics Announces Positive Opinion on Orphan Drug Designation Received from the European Medicines Agency for CTI-1601 for the Treatment of Friedreich’s Ataxia
Meet The Community: Zoë Graef
Meet The Community: Osama Alawik
Larimar Therapeutics Announces Dosing of Patients in Third Cohort of Phase 1 SAD Trial of CTI-1601 for Treatment of Friedreich’s Ataxia
Meet The Community: Brett Davis
Meet The Community: Matthew Jordan Penman
Meet The Community: María Luisa Ledesma Cano
Meet The Community: Elsaid Younes
Meet The Community: Julia Mancebo López
